118 related articles for article (PubMed ID: 11583782)
1. Syntheses, structures, stability, and insulin-like activities of peroxovanadium(V) complexes with a heteroligand.
Kanamori K; Nishida K; Miyata N; Okamoto K; Miyoshi Y; Tamura A; Sakurai H
J Inorg Biochem; 2001 Oct; 86(4):649-56. PubMed ID: 11583782
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S
J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639
[TBL] [Abstract][Full Text] [Related]
3. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
Adachi Y; Sakurai H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear and dinuclear monoperoxovanadium(v) complexes with a hetero ligand. 1.(1) Self-decomposition reaction, detection of reactive oxygen species, and oxidizing ability.
Kanamori K; Nishida K; Miyata N; Shimoyama T; Hata K; Mihara C; Okamoto K; Abe Y; Hayakawa S; Matsugo S
Inorg Chem; 2004 Nov; 43(22):7127-40. PubMed ID: 15500351
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode.
Rangel M; Tamura A; Fukushima C; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405
[TBL] [Abstract][Full Text] [Related]
6. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
7. Peroxo heteroligand vanadates(V): synthesis, spectra-structure relationships, and stability toward decomposition.
Djordjevic C; Vuletic N; Renslo ML; Puryear BC; Alimard R
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):25-9. PubMed ID: 8927044
[TBL] [Abstract][Full Text] [Related]
8. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
Sakurai H; Sano H; Takino T; Yasui H
J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
[TBL] [Abstract][Full Text] [Related]
9. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
10. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.
Kawabe K; Sasagawa T; Yoshikawa Y; Ichimura A; Kumekawa K; Yanagihara N; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2003 Nov; 8(8):893-906. PubMed ID: 14551811
[TBL] [Abstract][Full Text] [Related]
12. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
13. 4-Hydroxypyridine-2,6-dicarboxylatodioxovanadate(V) complexes: solid state and aqueous chemistry.
Yang L; la Cour A; Anderson OP; Crans DC
Inorg Chem; 2002 Dec; 41(24):6322-31. PubMed ID: 12444775
[TBL] [Abstract][Full Text] [Related]
14. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
15. Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.
Mukherjee T; Costa Pessoa J; Kumar A; Sarkar AR
Inorg Chem; 2011 May; 50(10):4349-61. PubMed ID: 21495653
[TBL] [Abstract][Full Text] [Related]
16. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of inhibition of rabbit intestine alkaline phosphatase by heteroligand peroxo complexes of vanadium(V) and tungsten(VI).
Kalita D; Das SP; Islam NS
Biol Trace Elem Res; 2009 Jun; 128(3):200-19. PubMed ID: 19034394
[TBL] [Abstract][Full Text] [Related]
18. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Sekiguchi F; Obata M; Ohtsuki C; Adachi Y; Sakurai H; Orvig C; Rehder D; Yano S
J Inorg Biochem; 2005 Jun; 99(6):1275-82. PubMed ID: 15917081
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and crystal structure of novel mononuclear peroxotungsten(VI) complexes. Insulinomimetic activity of W(VI) and Nb(V) peroxo complexes.
Maniatakou A; Karaliota S; Mavri M; Raptopoulou C; Terzis A; Karaliota A
J Inorg Biochem; 2009 May; 103(5):859-68. PubMed ID: 19342100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
